Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

ClinicalTrials.gov ID: NCT02522481

Public ClinicalTrials.gov record NCT02522481. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease

Study identification

NCT ID
NCT02522481
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bracco Diagnostics, Inc
Industry
Enrollment
175 participants

Conditions and interventions

Interventions

  • Lumason Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 23, 2015
Primary completion
Nov 6, 2017
Completion
Feb 24, 2018
Last update posted
Jun 10, 2021

2015 – 2018

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Sarver Heart Center, University of Arizona Tucson Arizona 85724
University of California San Diego La Jolla California 92037
Interventional Cardiology Medical Group, Inc. West Hills California 91037
Cardiology Physicians, PA Newark Delaware 19713
Community Heart and Vascular Community Hospital East Indianapolis Indiana 46250
St. Luke's Mid-America Heart Institute Kansas City Missouri 64111
North Kansas City Hospital North Kansas City Missouri 64116
Morristown Medical Center Morristown New Jersey 07960
The Institute for Clinical Research Holy Name Medical Center Teaneck New Jersey 07666
Mount Sinai Medical Center New York New York 10029

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02522481, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02522481 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →